Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 1070 Records) |
Query Trace: Colorectal Neoplasms and Braf[original query] |
---|
The Impact of Sidedness on the Efficacy of Anti-EGFR-Based First-Line Chemotherapy in Advanced Colorectal Cancer Patients in Real-Life Setting-A Nation-Wide Retrospective Analysis (RACER). Cancers 2023 9 15 (17): . Pawe? Micha? Potocki, Rafa? Wi?niowski, Dominik Haus, Zbyszko Chowaniec, Maciej Kozaczka, Magdalena Kustra, Marzenna Samborska-Plewicka, Marcin Szweda, Danuta Starzyczny-S?ota, Magdalena Michalik, Grzegorz S?omian, Aneta Lebiedzi?ska, Natalia Jonak-Olczyk, Natalia ?aszewska-Krai?ska, Krzysztof Adamowicz, Piotr Kolenda, Anna Drosik-Kwa?niewska, Marek Szwiec, Robert Dziura, Justyna Czech, Maria D?browska, Ewa Nowakowska-Zajdel, Ewa Klank-Soko?owska, Kamil Konopka, ?ukasz Kwinta, Jolanta Dobrza?ska, Piotr J Wysoc |
The effect of BRAF mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer - A post-hoc exploratory analysis of the randomized NORDIC9-study. Journal of geriatric oncology 2023 9 101632. Gabor Liposits, Stine B Winther, Jesper Ryg, Halla Skuladottir, Sören Möller, Eva Hofsli, Carl-Henrik Shah, Laurids Østergaard Poulsen, Åke Berglund, Camilla Qvortrup, Pia Osterlund, Bengt Glimelius, Halfdan Sorbye, Per Pfeiff |
KRAS/NRAS Mutations Associated with Distant Metastasis and BRAF/PIK3CA Mutations Associated with Poor Tumor Differentiation in Colorectal Cancer. International journal of general medicine 2023 9 16 4109-4120. Juanzi Zeng, Wenwei Fan, Jiaquan Li, Guowu Wu, Heming |
Estimating Venous Thromboembolism Risk in Metastatic Colorectal Cancer Inpatients: Validation of Existing Risk Scores and Development of New Risk Scores. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2023 9 29 10760296231196859. Li Qin, Zhikun Liang, Jingwen Xie, Xiaoyan |
KRAS and BRAF Mutation Rates and Survival Outcomes in Colorectal Cancer in an Ethnically Diverse Patient Cohort. International journal of molecular sciences 2023 12 24 (24): . Paul Habashy, Vivienne Lea, Kate Wilkinson, Bin Wang, Xiao-Juan Wu, Tara Laurine Roberts, Weng Ng, Tristan Rutland, Joseph William Po, Therese Becker, Joseph Descallar, Mark Lee, Scott Mackenzie, Ruta Gupta, Wendy Cooper, Stephanie Lim, Wei Chua, Cheok Soon L |
Real-World Outcomes of First-Line FOLFIRI Plus Bevacizumab with Irinotecan Dose Escalation versus FOLFOXIRI Plus Bevacizumab in BRAF-Mutant Metastatic Colorectal Cancer: The Preliminary Data from a Single-Center Observational Study. Medicina (Kaunas, Lithuania) 2023 12 59 (12): . Hsiang-Lin Tsai, Ching-Wen Huang, Yen-Cheng Chen, Wei-Chih Su, Tsung-Kun Chang, Po-Jung Chen, Ching-Chun Li, Yu-Tang Chang, Jaw-Yuan Wa |
Progress report of a cross-organ and biomarker-based basket-type clinical trial: BELIEVE Trial. Cancer science 2023 12 . Yayoi Ando, Tatsunori Shimoi, Kuniko Sunami, Natsuko Okita, Kenichi Nakamura, Taro Shibata, Yasuhiro Fujiwara, Noboru Yamamo |
Concomitant Non-V600E BRAF and KRAS Mutations in Colorectal Carcinoma by Next-Generation Sequencing: A Distinct Subtype. International journal of surgical pathology 2023 12 10668969231215425. Pallavi Srivastava, Sridhar Mishra, Saumya Shukla, Pooja Sharma, Nuzhat Husa |
Negative hyperselection of elderly patients with RAS and BRAF wild-type metastatic colorectal cancer receiving initial panitumumab plus FOLFOX or 5-FU/LV. European journal of cancer (Oxford, England : 1990) 2023 11 195 113396. Filippo Pietrantonio, Francesca Bergamo, Daniele Rossini, Filippo Ghelardi, Maria Caterina De Grandis, Marco Maria Germani, Giulia Barsotti, Vincenzo Formica, Giovanni Luca Frassineti, Giorgia Boscolo, Saverio Cinieri, Samantha Di Donato, Lorenzo Antonuzzo, Carlotta Antoniotti, Margherita Ambrosini, Vittoria Matilde Piva, Federico Nichetti, Matteo Fassan, Chiara Cremolini, Sara Lonar |
Association of KRAS, NRAS, BRAF and PIK3CA gene mutations with clinicopathological features, prognosis and ring finger protein 215 expression in patients with colorectal cancer. Biomedical reports 2023 11 19 (6): 104. Jing-Bo Wu, Xiao-Jing Li, Hui Liu, Yong-Juan Liu, Xiu-Ping L |
Comprehensive genomic profiling reveals prognostic signatures and insights into the molecular landscape of colorectal cancer. Frontiers in oncology 2023 11 13 1285508. Jinwei Yang, Sihui Zhao, Junyan Su, Siyao Liu, Zaozao Wu, Wei Ma, Ming Tang, Jingcui Wu, Erdong Mao, Li Han, Mengyuan Liu, Jiali Zhang, Lei Cao, Jingyi Shao, Yun Sha |
Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis. BMC cancer 2023 11 23 (1): 1117. Xiaona Lu, Yuyao Li, Yue Li, Xuemei Zhang, Jia Shi, Hai Feng, Zhuo Yu, Yueqiu G |
Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian population. PloS one 2023 10 18 (10): e0292087. Udit Nindra, Abhijit Pal, Vivienne Lea, Stephanie Hui-Su Lim, Kate Wilkinson, Ray Asghari, Tara L Roberts, Therese M Becker, Mahtab Farzin, Tristan Rutland, Mark Lee, Scott MacKenzie, Weng Ng, Bin Wang, C Soon Lee, Wei Ch |
EARLY-ONSET COLORECTAL CANCER: AN ELEVEN-YEAR ANALYSIS OF CLINICOPATHOLOGICAL CHARACTERISTICS AT A TERTIARY HEALTHCARE CENTER. Arquivos de gastroenterologia 2023 10 60 (3): 315-321. Jean Félix Piñerúa-Gonsálvez, Rosanna Del Carmen Zambrano-Infantino, María Antonella Rizzo-Rodríguez, Aurelio Dueñas-Diez, Luis Fernández-Salaz |
Tumor Testing and Genetic Analysis to Identify Lynch Syndrome Patients in an Italian Colorectal Cancer Cohort. Cancers 2023 10 15 (20): . Antonino Pantaleo, Giovanna Forte, Filomena Cariola, Anna Maria Valentini, Candida Fasano, Paola Sanese, Valentina Grossi, Antonia Lucia Buonadonna, Katia De Marco, Martina Lepore Signorile, Anna Filomena Guglielmi, Andrea Manghisi, Gianluigi Gigante, Raffaele Armentano, Vittoria Disciglio, Cristiano Simo |
Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer. Current issues in molecular biology 2023 10 45 (10): 7803-7812. ?vo Gökmen, Ebru Ta?tekin, Nazan Demir, Erkan Özcan, Fahri Akgül, Muhammed Bekir Hac?o?lu, Bülent Erdo?an, Sernaz Topalo?lu, ?rfan Çiç |
Circulating tumor DNA, and clinical features to guide rechallenge with BRAF inhibitors in BRAF-V600E mutated metastatic colorectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology 2023 10 . Javier Ros, Ana Vivancos, Josep Tabernero, Elena Él |
Impact of Posaconazole and Diltiazem on Pharmacokinetics of Encorafenib, a BRAF V600 Kinase Inhibitor for Melanoma and Colorectal Cancer with BRAF Mutations. Clinical and translational science 2023 10 . Erik Hahn, Renae Chavira, Lance Wollenberg, Weiwei Tan, Micaela B Red |
Epidemiological and clinicopathological features of KRAS, NRAS, BRAF mutations and MSI in Chinese patients with stage I-III colorectal cancer. Medicine 2024 4 103 (14): e37693. Weicheng Wang, Rui Wang, Xiao Han, Wei Zhang, Lijun Zhu, Yanhong |
Testing region selection and prognostic analysis of MLH1 promoter methylation in colorectal cancer in China. Gastroenterology report 2024 4 12 goae011. Xiaoli Tan, Yongzhen Fang, Xinjuan Fan, Weihao Deng, Jinglin Huang, Yacheng Cai, Jiaxin Zou, Zhiting Chen, Hanjie Lin, Liang Xu, Guannan Wang, Huanmiao Zhan, Shuhui Huang, Xinhui |
Correlation between NGS panel-based mutation results and clinical information in colorectal cancer patients. Heliyon 2024 4 10 (7): e29299. Bo Cheng, Lin Xu, Yunzhi Zhang, Huimin Yang, Shan Liu, Shanshan Ding, Huan Zhao, Yi Sui, Chan Wang, Lanju Quan, Jinhong Liu, Ye Liu, Hongming Wang, Zhaoqing Zheng, Xizhao Wu, Jing Guo, Zhaohong Wen, Ruya Zhang, Fei Wang, Hongmei Liu, Suozhu S |
BRAF mutations and survival with surgery for colorectal liver metastases: A systematic review and meta-analysis. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2024 4 50 (6): 108306. Fausto Petrelli, Marcella Arru, Silvia Colombo, Matteo Cavallone, Fulvia Milena Cribiu', Viola Villardita, Paola Floris, Luciano Digiesi, Gabriele Severgnini, Mariana Teixeira Moraes, Barbara Conti, Andrea Celotti, Matteo Viti, Andrea Soz |
Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist? British journal of cancer 2024 1 . Débora Contreras-Toledo, Paula Jiménez-Fonseca, Carlos López López, Ana Fernández Montes, Ana María López Muñoz, Francisca Vázquez Rivera, Vicente Alonso, Julia Alcaide, Francesc Salvà, Marta Covela Rúa, Mónica Guillot, Alfonso Martín Carnicero, Raquel Jimeno Mate, Soledad Cameselle García, Elena Asensio Martínez, Beatriz González Astorga, Amaya B Fernandez-Diaz, Paula González Villaroel, Anna C Virgili Manrique, Marcos Melián Sosa, Beatriz Alonso, Antia Cousillas Castiñeiras, Carmen Castañón López, Jorge Aparicio, Alberto Carmona-Bayon |
Clinical-Molecular characteristics and Post-Translational modifications of colorectal cancer in north China: Implications for future targeted therapies. Gene 2024 1 899 148134. Yajing Chi, Hongtu Yuan, Qing Fan, Zhendan Wang, Zuoxing Niu, Jinming Yu, Dandan Yu |
Reclassification of RAS/BRAF allele mutations predicts the survival benefit of triplet chemotherapy in metastatic colorectal cancer. Therapeutic advances in medical oncology 2024 1 16 17588359231225035. Xiang Zhang, Haizhong Ma, Yinjun He, Wenguang He, Nan Chen, Yandong Li, Weixiang Zhong, Guosheng Wu, Xile Zhou, Hanju Hua, Feng Ye, Hui Cai, Weiqin Jia |
Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal Cancer Patients: An Exploratory Study. Current oncology (Toronto, Ont.) 2024 1 31 (1): 274-295. Juan Pablo Cayún, Leslie Carol Cerpa, Alicia Colombo, Dante Daniel Cáceres, José Luis Leal, Felipe Reyes, Carolina Gutiérrez-Cáceres, Susan Calfunao, Nelson Miguel Varela, Luis Abel Quiñon |
Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patients. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2024 1 . Emmanuelle Samalin, Thibault Mazard, Eric Assenat, Magali Rouyer, Christelle de la Fouchardière, Rosine Guimbaud, Denis Smith, Fabienne Portales, Marc Ychou, Antoine Adenis, Catherine Fiess, Evelyne Lopez-Crapez, Simon Thezen |
A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy. International journal of molecular sciences 2024 1 25 (1): . Karen Gambaro, Maud Marques, Suzan McNamara, Mathilde Couetoux du Tertre, Cyrla Hoffert, Archana Srivastava, Anna Schab, Thierry Alcindor, Adrian Langleben, Lucas Sideris, Mahmoud Abdelsalam, Mustapha Tehfe, Felix Couture, Gerald Batist, Petr Kav |
BRAF Inhibitors in BRAF-Mutated Colorectal Cancer: A Systematic Review. Journal of clinical medicine 2024 1 13 (1): . Wajeeha Aiman, Muhammad Ashar Ali, Samer Jumean, Ummul Asfeen, Jose Garcia, Murad Quirem, Amaar Ahmad, Mohammad Nabil Rayad, Osama Alkhlaifat, Bader Al Omour, Venkata S Chemarthi, Michael Maroules, Gunwant Guron, Hamid Shaab |
Intratumoral presence of the genotoxic gut bacteria pks E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer. British journal of cancer 2024 1 . Jihoon E Joo, Yen Lin Chu, Peter Georgeson, Romy Walker, Khalid Mahmood, Mark Clendenning, Aaron L Meyers, Julia Como, Sharelle Joseland, Susan G Preston, Natalie Diepenhorst, Julie Toner, Danielle J Ingle, Norelle L Sherry, Andrew Metz, Brigid M Lynch, Roger L Milne, Melissa C Southey, John L Hopper, Aung Ko Win, Finlay A Macrae, Ingrid M Winship, Christophe Rosty, Mark A Jenkins, Daniel D Buchan |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: